NUVL |
Nuvalent, Inc. |
Director, Director by Deputization, 10%+ Owner |
$1.2B |
-$196M |
-14% |
Jun 18, 2025 |
SPRY |
ARS Pharmaceuticals, Inc. |
10%+ Owner |
$180M |
-$23.8M |
-11.7% |
Jun 27, 2025 |
AHCO |
AdaptHealth Corp. |
*Possible Member of 10% Group, 10%+ Owner |
$142M |
|
|
Mar 8, 2024 |
LRMR |
Larimar Therapeutics, Inc. |
Director, * Director by Deputization, 10%+ Owner |
$95.8M |
+$30M |
+45.6% |
Jul 31, 2025 |
MIRM |
Mirum Pharmaceuticals, Inc. |
* Possible Member of 10% Group, 10%+ Owner |
$91M |
|
|
Jun 6, 2022 |
CMAX |
CareMax, Inc. |
Director, Director by Deputization, 10%+ Owner |
$54.7M |
|
|
Nov 17, 2023 |
BCAX |
Bicara Therapeutics Inc. |
Possible Members of 10% Group, 10%+ Owner |
$23.8M |
|
|
Sep 17, 2024 |
TOI, DFPH |
Oncology Institute, Inc. |
Possible Members of 10% Group, 10%+ Owner |
$19.8M |
|
|
Nov 12, 2021 |
AFIB |
Acutus Medical, Inc. |
Director, Director by deputization |
$4.16M |
|
|
Jan 27, 2025 |
PEPG |
PepGen Inc. |
Possible Member of 10% Group, 10%+ Owner |
$3.97M |
|
|
May 10, 2022 |
OMIC |
Singular Genomics Systems, Inc. |
*Possible Member of 10% Group, 10%+ Owner |
$3.89M |
|
|
Jun 1, 2021 |
GUTS |
FRACTYL HEALTH, INC. |
Possible Members of 10% Group, 10%+ Owner |
$2.42M |
|
|
Feb 6, 2024 |
PHGE |
BiomX Inc. |
Director, *Director by Deputization |
$2.32M |
|
|
Apr 21, 2025 |
XLO |
Xilio Therapeutics, Inc. |
Possible Member of 10% Group, 10%+ Owner |
$1.9M |
|
|
Oct 26, 2021 |
FLAC |
Frazier Lifesciences Acquisition Corp |
Possible Member of 10% Group, 10%+ Owner |
|
|
|
Nov 8, 2022 |
ONCR |
Oncorus, Inc. |
Possible Member of 10% Group, 10%+ Owner |
|
|
|
Dec 28, 2022 |